Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, INmune Bio Inc’s stock clocked out at $5.22, up 5.24% from its previous closing price of $4.96. In other words, the price has increased by $5.24 from its previous closing price. On the day, 0.77 million shares were traded. INMB stock price reached its highest trading level at $5.745 during the session, while it also had its lowest trading level at $5.08.
Ratios:
To gain a deeper understanding of INMB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.36 and its Current Ratio is at 2.36. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on September 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $18.
On August 22, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $22.
On June 01, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $16.Robert W. Baird initiated its Outperform rating on June 01, 2023, with a $16 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 12 ’24 when Tesi Raymond Joseph bought 15,380 shares for $6.38 per share. The transaction valued at 98,048 led to the insider holds 1,554,106 shares of the business.
Moss David J bought 7,690 shares of INMB for $49,024 on Sep 12 ’24. The Chief Financial Officer now owns 1,275,869 shares after completing the transaction at $6.38 per share. On Jun 25 ’24, another insider, Juda Scott, who serves as the Director of the company, bought 5,000 shares for $7.27 each. As a result, the insider paid 36,350 and bolstered with 71,603 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMB now has a Market Capitalization of 103518856 and an Enterprise Value of 78425280. For the stock, the TTM Price-to-Sale (P/S) ratio is 1285.86 while its Price-to-Book (P/B) ratio in mrq is 2.77. Its current Enterprise Value per Revenue stands at 922.65.
Stock Price History:
Over the past 52 weeks, INMB has reached a high of $14.74, while it has fallen to a 52-week low of $4.81. The 50-Day Moving Average of the stock is -23.56%, while the 200-Day Moving Average is calculated to be -46.54%.
Shares Statistics:
It appears that INMB traded 227.59K shares on average per day over the past three months and 407690 shares per day over the past ten days. A total of 17.95M shares are outstanding, with a floating share count of 15.00M. Insiders hold about 32.34% of the company’s shares, while institutions hold 20.60% stake in the company. Shares short for INMB as of 1726185600 were 3156047 with a Short Ratio of 13.87, compared to 1723680000 on 2776206. Therefore, it implies a Short% of Shares Outstanding of 3156047 and a Short% of Float of 20.560000000000002.
